HCG Q1 FY27 results: consolidated PAT up 175% YoY, revenue rises 13%
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.4 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
HCG reported Q1 FY27 consolidated revenue of Rs 69,339 lakhs (up 13% YoY) and PAT of Rs 1,646 lakhs (up 175% YoY), EPS Rs 0.92. Standalone revenue rose 15% to Rs 37,525 lakhs with PAT of Rs 558 lakhs. Board approved Rs 16 crore additional investment in HCG Rajkot Hospitals LLP. Company completed sale of BACC Healthcare (infertility unit) to related party Inviga Healthcare Fund I for Rs 3,764 lakhs and acquired additional 34% in Vizag Hospital for Rs 15,450 lakhs. Statutory auditor issued unqualified limited review report.
Strong YoY profit growth shows operational scaling. Divestment of infertility unit and Vizag stake buyout signal active portfolio reshaping.